鼻咽癌放疗后甲状腺功能减退机器学习预测模型的开发与验证
最佳模型C指数训练0.91、验证0.71,简化五变量模型C指数训练0.80、验证0.71,高危患者三年RIHT发生率显著更高。
要点
- 101种组合ML框架中Coxboost+RSF法11变量模型性能最佳,验证C指数0.71。
- 简化五变量模型含治疗前TSH、TSH与甲状腺体积比、年龄、V45、V20,验证C指数0.71。
- 高危患者三年RIHT发生率训练队列72.3% vs 18.6%,验证队列67.9% vs 24.4%。
核心结论
- 开发了机器学习框架识别RIHT关键预测因素,并简化为五变量模型供临床预测RIHT风险。
主要发现
- 101种组合ML框架中Coxboost+RSF法11个预测变量模型性能最佳,C指数训练0.91、验证0.71。
- 多因素Cox回归构建的简化五变量模型C指数训练0.80、验证0.71。
- 训练队列高危患者三年RIHT发生率72.3% vs 18.6%(p<0.0001),验证队列67.9% vs 24.4%(p<0.0001)。
- 模型校准良好,决策曲线分析证实临床实用性。
关键数值与推荐
- 单因素Cox分析筛选显著变量(p<0.05),进一步用101种组合ML框架优化。
- 简化五变量模型纳入治疗前TSH、TSH与甲状腺体积比、年龄、V45、V20。
临床怎么用
- 五变量模型可用于鼻咽癌IMRT患者RIHT风险分层,辅助个体化治疗计划制定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: This study aims to develop a robust and user-friendly prediction model for radiation-induced hypothyroidism (RIHT) in nasopharyngeal carcinoma (NPC) patients. MATERIALS AND METHODS: NPC patients treated with IMRT between Jan. 2019 and Dec. 2021 were randomly assigned to a training cohort (n = 328) and a validation cohort (n = 141) at a ratio of 7:3. A total of 33 clinical and dose-volume variables were collected. Significant variables (p < 0.05) were identified through univariate Cox analysis and further refined using a 101-combination machine learning (ML) framework to develop a robust predictive model. The model was subsequently simplified through multivariate Cox analysis and a nomogram. Finally, the performance of the model was evaluated using the C-index, calibration plots, and decision curve analysis. RESULTS: Using a 101-combination ML framework, we developed a predictive model for RIHT in NPC. The Coxboost + RSF method with 11 predictors achieved the best performance (C-index: 0.91 [training], 0.71 [validation]). A simplified five-variable model (pre-treatment TSH, TSH-to-thyroid-volume ratio, age, V45, V20) was created via multi-cox regression, with a C-index of 0.80 [training] and 0.71 [validation]. High-risk patients had significantly higher three-year RIHT incidences (72.3% vs. 18.6%, p < 0.0001) in the training cohort, and 67.9% versus 24.4% (p < 0.0001) in the validation cohort. The model showed strong calibration and confirmed clinical utility through decision curve analysis, supporting its use in personalized treatment planning. CONCLUSION: We developed a ML framework to identify key predictive factors for RIHT, which was simplified into a five-variable model for clinical use, offering a robust tool for predicting RIHT risk in decision-making.
引用
- Zhong F, Zhou W, Gao X, et al. Development and validation of a machine learning-based model for predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma. Radiat Oncol. 2025. PMID: 41131611. doi:10.1186/s13014-025-02725-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。